Patrick lives in Virginia, with family history he is at increased risk. Virginia needs to do better.
Biomarker testing can improve cancer treatment outcomes, people in Virginia do not have equal access, even with insurance. bit.ly/biomarker-ad...
#biomarkertesting #ColorectalCancerAwarenessMonth
Biomarker testing can improve cancer treatment outcomes, people in Virginia do not have equal access, even with insurance. bit.ly/biomarker-ad...
#biomarkertesting #ColorectalCancerAwarenessMonth
March 12, 2025 at 3:01 PM
Patrick lives in Virginia, with family history he is at increased risk. Virginia needs to do better.
Biomarker testing can improve cancer treatment outcomes, people in Virginia do not have equal access, even with insurance. bit.ly/biomarker-ad...
#biomarkertesting #ColorectalCancerAwarenessMonth
Biomarker testing can improve cancer treatment outcomes, people in Virginia do not have equal access, even with insurance. bit.ly/biomarker-ad...
#biomarkertesting #ColorectalCancerAwarenessMonth
Curious why biomarker timing matters in NSCLC treatment? For Cancer Biomarker Awareness Day, check out this past Lung Cancer Considered discussion: bit.ly/489wK2Z
#biomarkertesting
#biomarkertesting
The Importance of Waiting for Biomarker Results in NSCLC | IASLC
Biomarkers are essential in lung cancer treatment, but they remain underutilized. In addition, clinicians and patients have to wait for those results before sta ...
bit.ly
November 14, 2025 at 12:11 AM
Curious why biomarker timing matters in NSCLC treatment? For Cancer Biomarker Awareness Day, check out this past Lung Cancer Considered discussion: bit.ly/489wK2Z
#biomarkertesting
#biomarkertesting
#Alzheimersdisease #Alzheimersdiagnosis #EliLilly #AlzheimerEuropeConference #AdelphiRealWorldDementiaDiseaseSpecificProgramme #underdiagnosisofAlzheimersdisease #AD #biomarkertesting #GeriatricPsychiatry #ADcare #AlzheimerEurope #ADdiagnosis #Alzheimersdiseasecare
zurl.co/eEoCY
zurl.co/eEoCY
Experts call for urgent action to improve Alzheimer’s diagnosis across Europe - PharmaTimes
New survey reveals critical gaps in access to testing and timely care
pharmatimes.com
October 8, 2025 at 9:51 AM
At 57, Colin Barton, was diagnosed with stage 4 lung cancer & given 2 yrs to live.
#BiomarkerTesting changed everything: it found ALK. Targeted treatment gave him not only more time, but the drive to co-found @ALKPositiveinc.
We want everyone to be lucky
corporate.thermofisher.com/us/en/index/...
#BiomarkerTesting changed everything: it found ALK. Targeted treatment gave him not only more time, but the drive to co-found @ALKPositiveinc.
We want everyone to be lucky
corporate.thermofisher.com/us/en/index/...
September 18, 2025 at 1:42 PM
At 57, Colin Barton, was diagnosed with stage 4 lung cancer & given 2 yrs to live.
#BiomarkerTesting changed everything: it found ALK. Targeted treatment gave him not only more time, but the drive to co-found @ALKPositiveinc.
We want everyone to be lucky
corporate.thermofisher.com/us/en/index/...
#BiomarkerTesting changed everything: it found ALK. Targeted treatment gave him not only more time, but the drive to co-found @ALKPositiveinc.
We want everyone to be lucky
corporate.thermofisher.com/us/en/index/...
The survey questions were grouped under 5 broad topics related to #BiomarkerTesting
📌Pre-testing communication
📌How results were 1st provided & reviewed
📌Results communication
📌Emotional impact of results
📌Preferred messaging (what patients wanted to hear)
#CRCSM #GI25 4/n
📌Pre-testing communication
📌How results were 1st provided & reviewed
📌Results communication
📌Emotional impact of results
📌Preferred messaging (what patients wanted to hear)
#CRCSM #GI25 4/n
January 26, 2025 at 4:55 AM
The survey questions were grouped under 5 broad topics related to #BiomarkerTesting
📌Pre-testing communication
📌How results were 1st provided & reviewed
📌Results communication
📌Emotional impact of results
📌Preferred messaging (what patients wanted to hear)
#CRCSM #GI25 4/n
📌Pre-testing communication
📌How results were 1st provided & reviewed
📌Results communication
📌Emotional impact of results
📌Preferred messaging (what patients wanted to hear)
#CRCSM #GI25 4/n
Have you or a loved one had biomarker testing?
If you feel comfortable sharing your experience, check out this form: https://vocalvideo.com/c/national-brain-tumor-society-share-your-story-national-brain-tumor-society-hkiiuwgw
#biomarkertesting #biomarker #biomarkers
If you feel comfortable sharing your experience, check out this form: https://vocalvideo.com/c/national-brain-tumor-society-share-your-story-national-brain-tumor-society-hkiiuwgw
#biomarkertesting #biomarker #biomarkers
August 24, 2025 at 2:02 AM
Have you or a loved one had biomarker testing?
If you feel comfortable sharing your experience, check out this form: https://vocalvideo.com/c/national-brain-tumor-society-share-your-story-national-brain-tumor-society-hkiiuwgw
#biomarkertesting #biomarker #biomarkers
If you feel comfortable sharing your experience, check out this form: https://vocalvideo.com/c/national-brain-tumor-society-share-your-story-national-brain-tumor-society-hkiiuwgw
#biomarkertesting #biomarker #biomarkers
The U.S. must expand access to and coverage for #NewbornScreening, #BiomarkerTesting and rapid #WholeGenomeSequencing, which have been crucial for the early diagnosis of certain #RareDiseases, says NORD Analyst Mason Barrett. He outlines what's needed to get there: thepathologist.com/issues/2025/...
Innovating in Rare Diseases: Together!
A roundtable discussion on the rare disease landscape and diagnostic directions
thepathologist.com
March 28, 2025 at 8:22 PM
The U.S. must expand access to and coverage for #NewbornScreening, #BiomarkerTesting and rapid #WholeGenomeSequencing, which have been crucial for the early diagnosis of certain #RareDiseases, says NORD Analyst Mason Barrett. He outlines what's needed to get there: thepathologist.com/issues/2025/...
As #BiomarkerTesting grows in #PrecisionOncology, understanding how tumor findings inform hereditary cancer risk assessment is critical.
This interactive @jacksonlab.bsky.social course helps GCs strengthen interpretation of biomarker testing using real-world clinical scenarios. #GeneChat
This interactive @jacksonlab.bsky.social course helps GCs strengthen interpretation of biomarker testing using real-world clinical scenarios. #GeneChat
January 12, 2026 at 1:27 PM
As #BiomarkerTesting grows in #PrecisionOncology, understanding how tumor findings inform hereditary cancer risk assessment is critical.
This interactive @jacksonlab.bsky.social course helps GCs strengthen interpretation of biomarker testing using real-world clinical scenarios. #GeneChat
This interactive @jacksonlab.bsky.social course helps GCs strengthen interpretation of biomarker testing using real-world clinical scenarios. #GeneChat
For each question, Julie& I had recommendations for clinicians.
For example, in our survey in colontown 31% of respondents indicated that "nothing was discussed" about #BiomarkerTesting before testing was done.
Our recommendation? see 💡below.
#CRCSM #GI25 5/n
For example, in our survey in colontown 31% of respondents indicated that "nothing was discussed" about #BiomarkerTesting before testing was done.
Our recommendation? see 💡below.
#CRCSM #GI25 5/n
January 26, 2025 at 4:56 AM
For each question, Julie& I had recommendations for clinicians.
For example, in our survey in colontown 31% of respondents indicated that "nothing was discussed" about #BiomarkerTesting before testing was done.
Our recommendation? see 💡below.
#CRCSM #GI25 5/n
For example, in our survey in colontown 31% of respondents indicated that "nothing was discussed" about #BiomarkerTesting before testing was done.
Our recommendation? see 💡below.
#CRCSM #GI25 5/n
Jung A benefitted from #BiomarkerTesting & has been advocating for legislation that would decrease barriers to this testing in MA. She spoke at ACS CAN Massachusetts Cancer Action Day, their Research Breakfast & testified in front of the legislature. We’re lucky to have volunteers like her! (3/3)
May 23, 2025 at 4:42 PM
Jung A benefitted from #BiomarkerTesting & has been advocating for legislation that would decrease barriers to this testing in MA. She spoke at ACS CAN Massachusetts Cancer Action Day, their Research Breakfast & testified in front of the legislature. We’re lucky to have volunteers like her! (3/3)
Excited to be joining @acscan.bsky.social to advocate for increased access to and insurance coverage for #BiomarkerTesting for individuals living with cancer in Delaware!
#oncsky #oncologynursing #canceradvocacy #nurseslead #precisionmedicine
#oncsky #oncologynursing #canceradvocacy #nurseslead #precisionmedicine
May 13, 2025 at 10:19 AM
Excited to be joining @acscan.bsky.social to advocate for increased access to and insurance coverage for #BiomarkerTesting for individuals living with cancer in Delaware!
#oncsky #oncologynursing #canceradvocacy #nurseslead #precisionmedicine
#oncsky #oncologynursing #canceradvocacy #nurseslead #precisionmedicine
SPCC: Outlook for the HR+/HER2- MBC treatment landscape in 2025 and beyond
oncodaily.com/blog/227603
#BiomarkerTesting #Cancer #CancerResearch #CancerTherapy #CancerTreatmentAdvancements #ClinicalCharacteristics #HR+/HER2-MBC #MetastaticBreastCancer #OncoDaily #Health #Medicine
oncodaily.com/blog/227603
#BiomarkerTesting #Cancer #CancerResearch #CancerTherapy #CancerTreatmentAdvancements #ClinicalCharacteristics #HR+/HER2-MBC #MetastaticBreastCancer #OncoDaily #Health #Medicine
SPCC: Outlook for the HR+/HER2- MBC treatment landscape in 2025 and beyond - OncoDaily
SPCC: Outlook for the HR+/HER2- MBC treatment landscape in 2025 and beyond / biomarker testing, cancer, Cancer research, cancer therapy, cancer treatment
oncodaily.com
January 21, 2025 at 1:41 PM
SPCC: Outlook for the HR+/HER2- MBC treatment landscape in 2025 and beyond
oncodaily.com/blog/227603
#BiomarkerTesting #Cancer #CancerResearch #CancerTherapy #CancerTreatmentAdvancements #ClinicalCharacteristics #HR+/HER2-MBC #MetastaticBreastCancer #OncoDaily #Health #Medicine
oncodaily.com/blog/227603
#BiomarkerTesting #Cancer #CancerResearch #CancerTherapy #CancerTreatmentAdvancements #ClinicalCharacteristics #HR+/HER2-MBC #MetastaticBreastCancer #OncoDaily #Health #Medicine
Vermont just made a groundbreaking move by mandating health insurance coverage for biomarker testing, revolutionizing patient care!
Click to read more!
#VT #PatientCare #VermontHealthcare #BiomarkerTesting #CitizenPortal #HealthcareAccess
Click to read more!
#VT #PatientCare #VermontHealthcare #BiomarkerTesting #CitizenPortal #HealthcareAccess
Vermont mandates health insurance coverage for biomarker testing under new law
Vermont law requires health insurance plans to cover biomarker testing for patient care.
citizenportal.ai
May 9, 2025 at 10:20 PM
Vermont just made a groundbreaking move by mandating health insurance coverage for biomarker testing, revolutionizing patient care!
Click to read more!
#VT #PatientCare #VermontHealthcare #BiomarkerTesting #CitizenPortal #HealthcareAccess
Click to read more!
#VT #PatientCare #VermontHealthcare #BiomarkerTesting #CitizenPortal #HealthcareAccess
LUNGevity Foundation - Start a conversation with your patients about the importance of biomarker testing
@lungevity.bsky.social
oncodaily.com/blog/239227
#BiomarkerTesting #Cancer #LUNGevityFoundation #NSCLC #OncoDaily #Oncology #WorldCancerDay #Medicine #Health
@lungevity.bsky.social
oncodaily.com/blog/239227
#BiomarkerTesting #Cancer #LUNGevityFoundation #NSCLC #OncoDaily #Oncology #WorldCancerDay #Medicine #Health
Start a conversation with your patients about the importance of biomarker testing - LUNGevity Foundation - OncoDaily
Start a conversation with your patients about the importance of biomarker testing - LUNGevity Foundation / biomarker testing, cancer, LUNGevity Foundation,
oncodaily.com
February 6, 2025 at 5:22 PM
LUNGevity Foundation - Start a conversation with your patients about the importance of biomarker testing
@lungevity.bsky.social
oncodaily.com/blog/239227
#BiomarkerTesting #Cancer #LUNGevityFoundation #NSCLC #OncoDaily #Oncology #WorldCancerDay #Medicine #Health
@lungevity.bsky.social
oncodaily.com/blog/239227
#BiomarkerTesting #Cancer #LUNGevityFoundation #NSCLC #OncoDaily #Oncology #WorldCancerDay #Medicine #Health
Don’t miss this 🎧:
Our board & medical committee member Marc Muskavitch, PhD joins UpStage Lung Cancer’s podcast for a powerful convo on ALK+ #lungcancer.
Why early detection & #BiomarkerTesting are critical to improving outcomes.
#lcsm 🦻upstagelungcancer.org/podcasts/livin…
Our board & medical committee member Marc Muskavitch, PhD joins UpStage Lung Cancer’s podcast for a powerful convo on ALK+ #lungcancer.
Why early detection & #BiomarkerTesting are critical to improving outcomes.
#lcsm 🦻upstagelungcancer.org/podcasts/livin…
May 19, 2025 at 5:48 PM
Don’t miss this 🎧:
Our board & medical committee member Marc Muskavitch, PhD joins UpStage Lung Cancer’s podcast for a powerful convo on ALK+ #lungcancer.
Why early detection & #BiomarkerTesting are critical to improving outcomes.
#lcsm 🦻upstagelungcancer.org/podcasts/livin…
Our board & medical committee member Marc Muskavitch, PhD joins UpStage Lung Cancer’s podcast for a powerful convo on ALK+ #lungcancer.
Why early detection & #BiomarkerTesting are critical to improving outcomes.
#lcsm 🦻upstagelungcancer.org/podcasts/livin…
Lung Cancer Europe - Making Sure Biomarker Testing Is Available and Used for Everyone, Everywhere
@lungcancereurope.bsky.social
oncodaily.com/insight/biom...
#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #LungCancer #BiomarkerTesting
@lungcancereurope.bsky.social
oncodaily.com/insight/biom...
#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #LungCancer #BiomarkerTesting
Making Sure Biomarker Testing Is Available and Used for Everyone, Everywhere - Lung Cancer Europe - OncoDaily
Making Sure Biomarker Testing Is Available and Used for Everyone, Everywhere - Lung Cancer Europe / Amanda Young, biomarker testing, cancer, Casey Connolly,
oncodaily.com
July 28, 2025 at 9:21 PM
Lung Cancer Europe - Making Sure Biomarker Testing Is Available and Used for Everyone, Everywhere
@lungcancereurope.bsky.social
oncodaily.com/insight/biom...
#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #LungCancer #BiomarkerTesting
@lungcancereurope.bsky.social
oncodaily.com/insight/biom...
#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #LungCancer #BiomarkerTesting
All people with #NSCLC should get #biomarkertesting at diagnosis and at progression.
I didn't understand until a year later the true importance of what she had done for me! Now I try to get the word out to all patients, especially in Canada where access is inconsistent.
November 19, 2024 at 12:39 AM
All people with #NSCLC should get #biomarkertesting at diagnosis and at progression.
🚨And if you can't make the talk, swing by poster B580 on Tuesday 18th for a chat! We're a friendly bunch and love to chat! 🚨 #Alzheimers #BiomarkerTesting #Diagnosis
February 7, 2025 at 9:03 AM
🚨And if you can't make the talk, swing by poster B580 on Tuesday 18th for a chat! We're a friendly bunch and love to chat! 🚨 #Alzheimers #BiomarkerTesting #Diagnosis
In the next section of the survey, we gathered information about how results were 1st provided & reviewed.
57% of patients viewed #BiomarkerTesting results without their doctor present.
Our recommendation? see 💡below.
#CRCSM #GI25 6/n
57% of patients viewed #BiomarkerTesting results without their doctor present.
Our recommendation? see 💡below.
#CRCSM #GI25 6/n
January 26, 2025 at 4:57 AM
In the next section of the survey, we gathered information about how results were 1st provided & reviewed.
57% of patients viewed #BiomarkerTesting results without their doctor present.
Our recommendation? see 💡below.
#CRCSM #GI25 6/n
57% of patients viewed #BiomarkerTesting results without their doctor present.
Our recommendation? see 💡below.
#CRCSM #GI25 6/n
Learn more about #biomarkertesting through LUNGevity’s “No One Missed” campaign noonemissed.org
No One Missed | No One Missed Campaign
noonemissed.org
November 19, 2024 at 12:40 AM
Learn more about #biomarkertesting through LUNGevity’s “No One Missed” campaign noonemissed.org
Tennessee's Senate is taking crucial steps to enhance healthcare for children and advance biomarker testing—what's at stake for our future?
Click to read more!
#TN #TennesseeChildren #ProstheticsSupport #CitizenPortal #HealthcareAccess #BiomarkerTesting
Click to read more!
#TN #TennesseeChildren #ProstheticsSupport #CitizenPortal #HealthcareAccess #BiomarkerTesting
Senate discusses prosthetics and biomarker testing bills for children and healthcare advancement
Senate committee reviews bills on children's prosthetics and biomarker testing for diagnostic care.
citizenportal.ai
March 26, 2025 at 4:09 AM
Tennessee's Senate is taking crucial steps to enhance healthcare for children and advance biomarker testing—what's at stake for our future?
Click to read more!
#TN #TennesseeChildren #ProstheticsSupport #CitizenPortal #HealthcareAccess #BiomarkerTesting
Click to read more!
#TN #TennesseeChildren #ProstheticsSupport #CitizenPortal #HealthcareAccess #BiomarkerTesting
🧬 Today is Cancer Biomarker Awareness Day!
Cancer #biomarkertesting helps doctors match patients to best treatment based on the cancer’s unique biology. Ask your doctor about biomarker testing today!
Learn more at biomarkersmatter.org.
#CancerBiomarkers | #CancerBiomarkerDay
Cancer #biomarkertesting helps doctors match patients to best treatment based on the cancer’s unique biology. Ask your doctor about biomarker testing today!
Learn more at biomarkersmatter.org.
#CancerBiomarkers | #CancerBiomarkerDay
November 13, 2025 at 4:02 PM
🧬 Today is Cancer Biomarker Awareness Day!
Cancer #biomarkertesting helps doctors match patients to best treatment based on the cancer’s unique biology. Ask your doctor about biomarker testing today!
Learn more at biomarkersmatter.org.
#CancerBiomarkers | #CancerBiomarkerDay
Cancer #biomarkertesting helps doctors match patients to best treatment based on the cancer’s unique biology. Ask your doctor about biomarker testing today!
Learn more at biomarkersmatter.org.
#CancerBiomarkers | #CancerBiomarkerDay
Did you miss @jacksonlab.bsky.social's 🆓 Precision Oncology 101: Short Lessons for Busy Clinicians webinar series?
Watch ➡️ education.clinical.jax.org/page/precisi...
Each 30-minute recording provides insights into #BiomarkerTesting for therapeutic decision-making for #oncology providers. #OncoSky
Watch ➡️ education.clinical.jax.org/page/precisi...
Each 30-minute recording provides insights into #BiomarkerTesting for therapeutic decision-making for #oncology providers. #OncoSky
December 26, 2024 at 1:14 PM
Did you miss @jacksonlab.bsky.social's 🆓 Precision Oncology 101: Short Lessons for Busy Clinicians webinar series?
Watch ➡️ education.clinical.jax.org/page/precisi...
Each 30-minute recording provides insights into #BiomarkerTesting for therapeutic decision-making for #oncology providers. #OncoSky
Watch ➡️ education.clinical.jax.org/page/precisi...
Each 30-minute recording provides insights into #BiomarkerTesting for therapeutic decision-making for #oncology providers. #OncoSky
In @colontown, we have people posting their biomarker test results regularly asking what they mean. This made @cagirlinchi & I wonder how results of biomarker testing is communicated to patients. This poster is the result of our inquiry into this.
#BiomarkerTesting #CRCSM 1/n
#BiomarkerTesting #CRCSM 1/n
January 26, 2025 at 4:52 AM
In @colontown, we have people posting their biomarker test results regularly asking what they mean. This made @cagirlinchi & I wonder how results of biomarker testing is communicated to patients. This poster is the result of our inquiry into this.
#BiomarkerTesting #CRCSM 1/n
#BiomarkerTesting #CRCSM 1/n
For Bethany, Foundation Medicine’s biomarker tests helped provide an action plan for her and her care team to follow when her cancer progressed. Hear more about Bethany’s experience with #BiomarkerTesting. Click here for more: youtu.be/SjQlqlrN-r8
August 19, 2025 at 4:00 PM
For Bethany, Foundation Medicine’s biomarker tests helped provide an action plan for her and her care team to follow when her cancer progressed. Hear more about Bethany’s experience with #BiomarkerTesting. Click here for more: youtu.be/SjQlqlrN-r8